Delivery Order SPE2DB24D1007-SPE2DB24FBZJK

Award Date 5/8/24
Potential Completion Date 5/9/24
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of COSENTYX SENSOREADY 150 MG PENML medical products. The $61,417.09 firm fixed price delivery order has a completion date of February 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,859.83 firm fixed-price delivery order is for COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product, with a completion date of February 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,175.60 firm-fixed-price delivery order is for COSENTYX SENSOREADY 150 MG PEN ML, a specialty medication. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,043.90 firm fixed-price delivery order is for the supply of COSENTYX SENSOREADY 150 MG PEN medication and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025. This IDC serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) is valued up to $999,999,999.00 and runs through December 31, 2025. This contract serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $7,794.17 delivery order contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to provide this critical medical commodity to support government healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,016.23 firm fixed-price contract is for the supply of COSENTYX SENSOREADY 150 MG PENML, a specialty medication. The contract has an ultimate completion date of May 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,676.42 firm fixed price delivery order is for the provision of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $9,391.38 Firm Fixed Price Delivery Order contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has an ultimate completion date of August 30, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded multiple...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,702.77 firm fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. This contract award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB24FBZJK
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $5,871.99 Delivery Order contract is for the provision of COSENTYX SENSOREADY 150 MG PEN/ML, a prescription medication, with a completion date of May 9, 2024.

Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with both the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, to deliver a wide range of pharmaceutical products and medical supplies to support U.S. government agencies and military treatment programs worldwide. This contract award is not designated as a set-aside.

Generated 8/7/24, 10:17 AM